SCHEMBL578403

SCHEMBL578403

NC(=O)c1ccc2cncc(-c3ccc(O)cc3)c2n1

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CCNC P24863 16/20 0.67
CDK8 P49336 16/20 0.67
PIM1 P11309 1/20 0.45
RPS6KA3 P51812 1/20 0.40
FYN P06241 1/20 0.39
APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15747590 0.87 CCNC (0.65) CCNCCDK8PIM1RPS6KA3
SCHEMBL15742865 0.87 CCNC (0.65) CCNCCDK8PIM1
SCHEMBL15742747 0.87 CCNC (0.69) CCNCCDK8PIM1
SCHEMBL4580346 0.87 CCNC (0.64) CCNCCDK8PIM1RPS6KA3
SCHEMBL15742996 0.85 CCNC (0.62) CCNCCDK8PIM1
SCHEMBL15742774 0.83 CCNC (0.65) CCNCCDK8APP
SCHEMBL10138290 0.83 CCNC (0.65) CCNCCDK8PIM1
SCHEMBL28024783 0.83 CCNC (0.65) CCNCCDK8PIM1
SCHEMBL15747546 0.83 CCNC (0.61) CCNCCDK8
SCHEMBL15743027 0.83 CCNC (0.61) CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410273-B2 Cyclic compound having substituted phenyl group DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-04-02 US claimed
CN-102803223-A Cyclic compound having substituted phenyl group DAIICHI SANKYO CO LTD 2012-11-28 CN claimed
US-20120040936-A1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-02-16 US claimed
EP-2418203-A1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP Daiichi Sankyo Company, Limited (JP) 2012-02-15 EP claimed
EP-2418203-B1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP DAIICHI SANKYO CO LTD (JP) 2013-12-11 EP disclosed
US-8410273-B2 Cyclic compound having substituted phenyl group DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-04-02 US disclosed
CN-102803223-A Cyclic compound having substituted phenyl group DAIICHI SANKYO CO LTD 2012-11-28 CN disclosed
US-20120040936-A1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-02-16 US disclosed
EP-2418203-A1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP Daiichi Sankyo Company, Limited (JP) 2012-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040936-A1 CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP BMP2, BMP4, BMP6 CCNC 1592/4885CDK8 2959/4885PIM1 1092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.